Welcome to our dedicated page for Haymaker Acquisition news (Ticker: HYAC), a resource for investors and traders seeking the latest updates and insights on Haymaker Acquisition stock.
Haymaker Acquisition Corp. 4 was a blank-check company whose news centered on SPAC transaction activity, shareholder voting matters, material agreements, capital-structure updates and governance disclosures. Company developments included security-structure topics tied to units, Class A ordinary shares and warrants, as well as redemption-related actions and other matters connected with its completed business combination process.
Subsequent updates also reflected the issuer's corporate-status transition, including exchange delisting and termination or suspension of Exchange Act reporting obligations following the completed transaction.
Biote reported a net revenue of $37 million for Q1 2022, marking an 18% increase year-over-year. Procedural revenue surged by 21.2%. The adjusted EBITDA rose 20% to $12 million. The company is anticipating the completion of its business combination with Haymaker Acquisition Corp. III (NYSE: HYAC) in Q2 2022 and maintained its 2022 revenue guidance of $160-166 million and adjusted EBITDA guidance of $46-50 million.
Biote reported record financial results for 2021, with net sales of $139.4 million, a 20% increase year-over-year, and Q4 sales of $37.5 million, up 22% from the previous quarter. EBITDA rose to $36 million, marking a 9% increase year-over-year. The company anticipates revenue in the range of $160-166 million and EBITDA of $46-50 million for 2022, following a business combination with Haymaker Acquisition Corp. III (Nasdaq: HYAC) expected in Q2 2022, which will provide additional funding for expansion.
Biote reported record financial results for 2021, achieving net sales of $139.4 million (up 20% YoY) and fourth-quarter sales of $37.5 million (22% QoQ increase). The EBITDA for 2021 was $36 million, reflecting a 9% year-over-year rise. The company forecasts 2022 revenue between $160-166 million and EBITDA between $46-50 million. This growth is bolstered by a recent business combination with org value="NASDAQ-SMALL:HYAC"Haymaker Acquisition Corp. III expected to close in Q2 2022.
Biote, a leader in hormone optimization therapies, announced a definitive business combination with Haymaker Acquisition Corp. III (HYAC) valued at approximately $737 million. This merger is expected to close in the first half of 2022, allowing Biote to enhance its commercial footprint and support accelerated growth. Biote projects 2022 revenue between $160-$166 million with an Adjusted EBITDA of $46-$50 million. Post-transaction, the combined company will trade on Nasdaq under the symbol BTMD, expecting approximately $195 million in cash to facilitate further growth.
Haymaker Acquisition Corp. III (NASDAQ: HYACU) announced that starting April 22, 2021, holders of units from its IPO can trade shares of Class A common stock and redeemable warrants separately. Whole warrants will trade under the symbols HYAC and HYACW, while units that remain intact will continue to be listed as HYACU. This decision provides investors with greater flexibility in trading. Haymaker focuses on acquiring businesses in the consumer and consumer-related sectors, led by CEO Steven J. Heyer, among others.
Haymaker Acquisition Corp. III (NASDAQ: HYACU) has successfully closed its initial public offering, raising $300 million through the sale of 30 million units priced at $10.00 each. Proceeds are set to be placed in trust to facilitate future business combinations in the consumer sector. The offering was underwritten by Citigroup and Cantor Fitzgerald & Co. The SEC declared the registration statement effective on March 1, 2021.
Haymaker Acquisition Corp. III has priced its initial public offering (IPO) of 30,000,000 units at $10.00 per unit, with listing on NASDAQ under the ticker symbol HYACU starting March 2, 2021. Each unit includes one share of Class A common stock and one-fourth of a redeemable warrant, exercisable for $11.50 per share. The firm plans to acquire businesses in the consumer products sector, with CEO Steven J. Heyer and team leading the initiative. Underwriters Citigroup and Cantor Fitzgerald have a 45-day option for an additional 4,500,000 units.
ARKO Holdings, Ltd. has completed its acquisition of Empire Petroleum Partners, enhancing scale and diversifying its operations, which now encompass about 3,000 locations across 33 states. This acquisition is projected to double their annual fuel distribution to over 2 billion gallons. CEO Arie Kotler emphasizes the strategic importance of this deal for growth and competitiveness. The move coincides with ARKO's impending merger with Haymaker Acquisition Corp. II, expected to finalize in Q4 2020, leading to a public listing on NASDAQ under the ticker ARKO.
ARKO Corp. is set for strong growth post-merger with Haymaker Acquisition Corp.. Projected 2021 Pro-forma Adjusted EBITDA is expected to range from $210 to $215 million. GPM Investments, a leading convenience store chain in the U.S., will enhance its growth trajectory with a store count rising to 1,393 locations. The deal, pending shareholder approval, anticipates a $1.4 billion market cap at closing, with an estimated total enterprise value of $2 billion. A joint investor call is scheduled for September 9, 2020.